No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:49519200-49524000 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
2 |
chr6:49519400-49526600 |
Enhancers |
Hela-S3 |
cervix
|
3 |
chr6:49519400-49533600 |
Weak transcription |
Pancreas |
Pancrea
|
4 |
chr6:49520000-49524000 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
5 |
chr6:49520200-49524000 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
6 |
chr6:49520400-49524000 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
7 |
chr6:49520600-49529800 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
8 |
chr6:49520800-49524000 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
9 |
chr6:49521200-49525000 |
Weak transcription |
Esophagus |
oesophagus
|
10 |
chr6:49521400-49524200 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
11 |
chr6:49521600-49524000 |
Weak transcription |
NHDF-Ad |
bronchial
|
12 |
chr6:49522000-49524600 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
13 |
chr6:49522800-49534000 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
14 |
chr6:49523000-49524000 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
15 |
chr6:49523000-49524800 |
Enhancers |
HMEC |
breast
|
16 |
chr6:49523000-49525400 |
Weak transcription |
Stomach Mucosa |
stomach
|
17 |
chr6:49523400-49524600 |
Genic enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
18 |
chr6:49523600-49524200 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
19 |
chr6:49523600-49524200 |
Enhancers |
K562 |
blood
|
20 |
chr6:49523600-49524600 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
21 |
chr6:49523600-49524600 |
Bivalent Enhancer |
iPS-20b Cell Line |
embryonic stem cell
|
22 |
chr6:49523600-49524600 |
Enhancers |
NH-A |
brain
|
23 |
chr6:49523600-49524600 |
Flanking Active TSS |
NHEK |
skin
|
24 |
chr6:49523600-49530800 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
25 |
chr6:49523800-49524000 |
Enhancers |
Fetal Intestine Large |
intestine
|
26 |
chr6:49523800-49524200 |
Flanking Active TSS |
HUVEC |
blood vessel
|
27 |
chr6:49523800-49524600 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
28 |
chr6:49523800-49524600 |
Weak transcription |
Fetal Intestine Small |
intestine
|
29 |
chr6:49523800-49524800 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
30 |
chr6:49523800-49524800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
31 |
chr6:49523800-49524800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
32 |
chr6:49523800-49524800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
33 |
chr6:49523800-49524800 |
Flanking Active TSS |
A549 |
lung
|
34 |
chr6:49523800-49525600 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
35 |
chr6:49523800-49526200 |
Enhancers |
HepG2 |
liver
|